Drug Trial Radar · NCT00029835
Obese Patients With Untreated Dyslipidemias
Last checked: Nov 20, 2026Latest source record: Apr 20, 2009 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,033
Actual
Start
Sep 2001
Primary completion
Nov 2003
Study completion Nov 2003
Sponsor
- Lead sponsor
- SanofiSanofi (SNY)
- Sponsor type
- Industry
- First posted
- Jan 24, 2002
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To assess the effect on weight loss and weight maintenance over a period of one year when prescribed with a hypocaloric diet in obese patients with untreated dyslipidemia
Conditions
- Obesity
- Dyslipidemia
Interventions
Rimonabant (SR141716)Drug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in body weight at 1 year.
Locations
35 sites in 8 countries. Site status is shown where the registry gives one.
Clinic of Physicians and Surgeons, LTD
Mesa, Arizona
Arizona Clinical Research Center, Inc.
Tucson, Arizona
Irvine Center for Clinical Research (ICCR)
Irvine, California
Los Angeles Clinical Trials
Los Angeles, California
Apexute
Santa Ana, California
Clinical Research of South Florida
Coral Gables, Florida
Radiant Research
Stuart, Florida
nTouch Research
Peoria, Illinois
nTouch Research
South Bend, Indiana
Bluegrass Clinical Research, Inc.
Louisville, Kentucky
Johns Hopkins Women's Research Core
Lutherville, Maryland
Baystate Medical Center
Springfield, Massachusetts
Twin Cities Clinical Research
Arden Hills, Minnesota
Radiant Research
Edina, Minnesota
Women's Clinic of Lincoln, PC
Lincoln, Nebraska
New Mexico Clinical Research & Osteoporosis Center, Inc.
Albuquerque, New Mexico
Clinical Research Services
Bismarck, North Dakota
University of Cincinnati College of Medicine
Cincinnati, Ohio
Altoona Center for Clinical Research
Duncansville, Pennsylvania
Clinical Research Division
Newtown, Pennsylvania
Clinical Research Center of Reading, LLC
West Reading, Pennsylvania
Medical University of South Carolina, Division of Clinical Pharmacology
Charleston, South Carolina
Nashville Medical Research Institute
Nashville, Tennessee
Radiant Research
Salt Lake City, Utah
Clinical Research Center of Northern Virginia
Falls Church, Virginia
Hunter Holmes McGuire Medical Center Research Service (151)
Richmond, Virginia
Vancouver Medical Weight Loss Clinic
Vancouver, Washington
Addiction & Psychiatric Medicine Research
Morgantown, West Virginia
Sanofi-aventis Administrative Office
Macquarie Park, Australia
Sanofi-aventis Administrative Office
Laval, Canada
Sanofi-aventis Administrative Office
Helsinki, Finland
Sanofi-aventis Administrative Office
Milan, Italy
Sanofi-aventis Administrative Office
Barcelona, Spain
Sanofi-aventis Administrative Office
Bromma, Sweden
Sanofi-aventis Administrative Office
Geneva, Switzerland
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.